BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 34827688)

  • 1. Expanding the Disorder-Function Paradigm in the C-Terminal Tails of Erbbs.
    Pinet L; Assrir N; van Heijenoort C
    Biomolecules; 2021 Nov; 11(11):. PubMed ID: 34827688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The src homology 2 and phosphotyrosine binding domains of the ShcC adaptor protein function as inhibitors of mitogenic signaling by the epidermal growth factor receptor.
    O'Bryan JP; Lambert QT; Der CJ
    J Biol Chem; 1998 Aug; 273(32):20431-7. PubMed ID: 9685397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mammalian adaptor protein with conserved Src homology 2 and phosphotyrosine-binding domains is related to Shc and is specifically expressed in the brain.
    O'Bryan JP; Songyang Z; Cantley L; Der CJ; Pawson T
    Proc Natl Acad Sci U S A; 1996 Apr; 93(7):2729-34. PubMed ID: 8610109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Src homology 2 domains enhance tyrosine phosphorylation
    Jadwin JA; Curran TG; Lafontaine AT; White FM; Mayer BJ
    J Biol Chem; 2018 Jan; 293(2):623-637. PubMed ID: 29162725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SH2 and PTB domains in tyrosine kinase signaling.
    Schlessinger J; Lemmon MA
    Sci STKE; 2003 Jul; 2003(191):RE12. PubMed ID: 12865499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A conserved amino-terminal Shc domain binds to phosphotyrosine motifs in activated receptors and phosphopeptides.
    van der Geer P; Wiley S; Lai VK; Olivier JP; Gish GD; Stephens R; Kaplan D; Shoelson S; Pawson T
    Curr Biol; 1995 Apr; 5(4):404-12. PubMed ID: 7542991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding affinities of tyrosine-phosphorylated peptides to the COOH-terminal SH2 and NH2-terminal phosphotyrosine binding domains of Shc.
    Zhou MM; Harlan JE; Wade WS; Crosby S; Ravichandran KS; Burakoff SJ; Fesik SW
    J Biol Chem; 1995 Dec; 270(52):31119-23. PubMed ID: 8537373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanisms of SH2- and PTB-domain-containing proteins in receptor tyrosine kinase signaling.
    Wagner MJ; Stacey MM; Liu BA; Pawson T
    Cold Spring Harb Perspect Biol; 2013 Dec; 5(12):a008987. PubMed ID: 24296166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SH2 and PTB domain interactions in tyrosine kinase signal transduction.
    Shoelson SE
    Curr Opin Chem Biol; 1997 Aug; 1(2):227-34. PubMed ID: 9667855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrin beta cytoplasmic domain interactions with phosphotyrosine-binding domains: a structural prototype for diversity in integrin signaling.
    Calderwood DA; Fujioka Y; de Pereda JM; GarcĂ­a-Alvarez B; Nakamoto T; Margolis B; McGlade CJ; Liddington RC; Ginsberg MH
    Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2272-7. PubMed ID: 12606711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between the phosphotyrosine binding domain of Shc and the insulin receptor is required for Shc phosphorylation by insulin in vivo.
    Isakoff SJ; Yu YP; Su YC; Blaikie P; Yajnik V; Rose E; Weidner KM; Sachs M; Margolis B; Skolnik EY
    J Biol Chem; 1996 Feb; 271(8):3959-62. PubMed ID: 8626723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FRS2 proteins recruit intracellular signaling pathways by binding to diverse targets on fibroblast growth factor and nerve growth factor receptors.
    Ong SH; Guy GR; Hadari YR; Laks S; Gotoh N; Schlessinger J; Lax I
    Mol Cell Biol; 2000 Feb; 20(3):979-89. PubMed ID: 10629055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tyr-317 phosphorylation increases Shc structural rigidity and reduces coupling of domain motions remote from the phosphorylation site as revealed by molecular dynamics simulations.
    Suenaga A; Kiyatkin AB; Hatakeyama M; Futatsugi N; Okimoto N; Hirano Y; Narumi T; Kawai A; Susukita R; Koishi T; Furusawa H; Yasuoka K; Takada N; Ohno Y; Taiji M; Ebisuzaki T; Hoek JB; Konagaya A; Kholodenko BN
    J Biol Chem; 2004 Feb; 279(6):4657-62. PubMed ID: 14613932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solution structure of the C-terminal SH2 domain of the human tyrosine kinase Syk complexed with a phosphotyrosine pentapeptide.
    Narula SS; Yuan RW; Adams SE; Green OM; Green J; Philips TB; Zydowsky LD; Botfield MC; Hatada M; Laird ER
    Structure; 1995 Oct; 3(10):1061-73. PubMed ID: 8590001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shc phosphotyrosine-binding domain dominantly interacts with epidermal growth factor receptors and mediates Ras activation in intact cells.
    Sakaguchi K; Okabayashi Y; Kido Y; Kimura S; Matsumura Y; Inushima K; Kasuga M
    Mol Endocrinol; 1998 Apr; 12(4):536-43. PubMed ID: 9544989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. En bloc substitution of the Src homology region 2 domain activates the transforming potential of the c-Abl protein tyrosine kinase.
    Muller AJ; Pendergast AM; Parmar K; Havlik MH; Rosenberg N; Witte ON
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3457-61. PubMed ID: 7682703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of electrostatic interactions in SH2 domain recognition: salt-dependence of tyrosyl-phosphorylated peptide binding to the tandem SH2 domain of the Syk kinase and the single SH2 domain of the Src kinase.
    Grucza RA; Bradshaw JM; Mitaxov V; Waksman G
    Biochemistry; 2000 Aug; 39(33):10072-81. PubMed ID: 10955995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural and biochemical evaluation of the interaction of the phosphatidylinositol 3-kinase p85alpha Src homology 2 domains with phosphoinositides and inositol polyphosphates.
    Surdo PL; Bottomley MJ; Arcaro A; Siegal G; Panayotou G; Sankar A; Gaffney PR; Riley AM; Potter BV; Waterfield MD; Driscoll PC
    J Biol Chem; 1999 May; 274(22):15678-85. PubMed ID: 10336465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Src binds cortactin through an SH2 domain cystine-mediated linkage.
    Evans JV; Ammer AG; Jett JE; Bolcato CA; Breaux JC; Martin KH; Culp MV; Gannett PM; Weed SA
    J Cell Sci; 2012 Dec; 125(Pt 24):6185-97. PubMed ID: 23097045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine.
    Okazaki T; Maeda A; Nishimura H; Kurosaki T; Honjo T
    Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13866-71. PubMed ID: 11698646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.